Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows
EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi
Exact Sciences Unveils Advances in Multi-Cancer Early Detection with Cancerguard™ Test
MSD and LaNova Medicines Enter Exclusive Global License Agreement for Novel Cancer Therapy, LM-299
Promising CAR T Cell Therapies from BMS and Cabaletta Bio Show Potential for Durable Remission in Severe Lupus
FDA Grants Accelerated Approval to PTC Therapeutics' KEBILIDI™, the First Gene Therapy for AADC Deficiency in the U.S.
Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Hospitals and Public Health Laboratories
Philips India Unveils Advanced Azurion Imaging System to Revolutionize Cardiac and Neurovascular Care
Tempus AI Study Highlights Benefits of Dual RNA and DNA Sequencing for Advanced Lung Cancer
Ontada and Datavant Partner to Expand Access to Real-World Oncology Data for Accelerated Cancer Innovation
Tempus AI and Flatiron Health Partner to Integrate Genomic Testing into OncoEMR for Enhanced Oncology Care
Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors
FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults
Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies
IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment
